Panacea Pharmaceuticals, Inc. is a development stage biopharmaceutical company focused on utilizing functional genomics and proteomics to develop therapeutics and diagnostics for cancer. The Company's technology pipeline includes drug development programs for central nervous system diseases, particularly Alzheimer's disease and Parkinson's disease.